[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100640425":3},{"organization":4,"armGroups":7,"interventions":19,"overallOfficials":24,"centralContacts":28,"locations":36,"responsibleParty":54,"collaborators":57,"id":61,"slug":62,"hasResults":63,"nctId":64,"briefTitle":65,"officialTitle":66,"acronym":10,"eligibilityCriteria":67,"healthyVolunteers":68,"sex":69,"minAge":70,"maxAge":10,"enrollmentInfo":71,"targetDuration":10,"studyType":74,"phases":10,"briefSummary":75,"conditions":76,"keywords":78,"overallStatus":81,"whyStopped":10,"lastUpdateSubmitDate":82,"lastUpdatePostDateStruct":83,"startDateStruct":86,"completionDateStruct":88,"leadSponsor":90,"locationsCount":91},{"fullName":5,"class":6},"University of Alabama at Birmingham","OTHER",[8,13,16],{"label":9,"type":10,"description":10,"interventionNames":11},"adolescent and young adult with congenital adrenal hyperplasia",null,[12],"Other: exposure to healthcare transition protocol",{"label":14,"type":10,"description":10,"interventionNames":15},"guardian\u002Fcaregiver of adolescent\u002Fyoung adult with congenital adrenal hyperplasia",[12],{"label":17,"type":10,"description":10,"interventionNames":18},"clinical provider of patients with congenital adrenal hyperplasia",[12],[20],{"type":6,"name":21,"description":22,"armGroupLabels":23,"otherNames":10},"exposure to healthcare transition protocol","CAH-T Curriculum Visits CAH-T Visit 1 (V1)\n\nCAH-T Visit 1 will occur approximately 3 months after enrollment and will include:\n\n* Review of CAH disease management\n* Stress dosing education\n* Emergency hydrocortisone instruction\n* Medical alert education\n* Teach-back demonstration of emergency injection technique\n* Discussion of adherence, mental health, fertility\u002Fsexual health, bone health, and cardiometabolic health\n* Introduction to healthcare transition concepts\n* Development of individualized transition goals\n\nFor participants aged ≥18 years:\n\n* Identification of adult endocrinology provider\n* Development of transfer plan\n* Medical summary review\u002Fupdate Relevant educational materials are included in attachments. CAH-T Visit 2 (V2)\n\nCAH-T Visit 2 will occur approximately 6 months after enrollment and will include:\n\n* Reinforcement of CAH self-management concepts\n* Review of emergency preparedness\n* Review of transfer readiness\n* Finalization of transfer planning",[9,17,14],[25],{"name":26,"affiliation":5,"role":27},"Christy Foster, MD","PRINCIPAL_INVESTIGATOR",[29,33],{"name":26,"role":30,"phone":31,"phoneExt":10,"email":32},"CONTACT","205-638-9107","cafoster@uabmc.edu",{"name":34,"role":30,"phone":10,"phoneExt":10,"email":35},"Leslie Pitts, PHD","lesliepitts@uab.edu",[37],{"facility":5,"status":10,"city":38,"state":39,"zip":40,"country":41,"countryCode":42,"cosmosGeoPoint":43,"geoPoint":48,"contacts":49},"Birmingham","Alabama","35233","United States","US",{"type":44,"coordinates":45},"Point",[46,47],-86.80249,33.52066,{"lat":47,"lon":46},[50,52],{"name":26,"role":30,"phone":51,"phoneExt":10,"email":32},"2056389107",{"name":53,"role":30,"phone":10,"phoneExt":10,"email":35},"Leslie Pitts, PhD",{"type":27,"investigatorFullName":55,"investigatorTitle":56,"investigatorAffiliation":5,"oldNameTitle":10,"oldOrganization":10},"Christy Foster","primary investigator",[58],{"name":59,"class":60},"Neurocrine Biosciences","INDUSTRY","100640425","development-of-healthcare-transition-for-patients-with-congenital-adrenal-hyperplasia-100640425",false,"NCT07611786","Development of Healthcare Transition for Patients With Congenital Adrenal Hyperplasia","Evaluation of a Healthcare Transition Protocol for Patients With Congenital Adrenal Hyperplasia","Inclusion Criteria:\n\nYA Participants\n\n* Diagnosis of congenital adrenal hyperplasia (any subtype or severity)\n* Age ≥16 years\n* Active follow-up within the pediatric endocrinology clinic\n* English-speaking\n* Cognitively able to complete questionnaires with or without assistance\n* Anticipated ability to participate in CAH-T visits during the study period Caregiver Participants\n* Parent, guardian, or primary support person of an enrolled AYA participant Provider Participants\n* Pediatric endocrinologists, nurse practitioners, or transition-related clinical staff involved in CAH care for at least 6 months\n\nExclusion Criteria:\n\n* Significant cognitive impairment precluding participation\n* Inability to complete study procedures\n* Inability to provide informed consent\u002Fassent",true,"ALL","16 Years",{"count":72,"type":73},40,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to implement and evaluate the feasibility and acceptability of a structured healthcare transition program for adolescents and young adults with congenital adrenal hyperplasia (CAH). The study will also examine preliminary effects of the program on transition readiness, disease-specific self-management knowledge, emergency preparedness, continuity of endocrine care, and health-related quality of life as participants transition from pediatric to adult healthcare services.",[77],"Congenital Adrenal Hyperplasia",[79,80],"congenital adrenal hyperplasia","healthcare transition","NOT_YET_RECRUITING","2026-06-29",{"date":84,"type":85},"2026-07-01","ACTUAL",{"date":87,"type":73},"2026-07",{"date":89,"type":73},"2029-07",{"name":5,"class":6},1]